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BACKGROUND AND PURPOSE: MR imaging features of metronidazole-induced encephalopathy (MIE)
have not been fully established. This study was undertaken to determine the topographic distributions
and diffusion-weighted imaging (DWI) findings of MIE.
MATERIALS AND METHODS: We retrospectively evaluated the initial MR images (n 7), including DWI
(n  5), and follow-up MR images (n  4) after drug discontinuation in 7 patents with clinically
diagnosed MIE. The topographic distributions of lesions were evaluated on MR images, and DWI
signal intensities and apparent diffusion coefficient (ADC) values of the lesions were assessed.
RESULTS: MR images demonstrated bilateral symmetric T2 hyperintense lesions in the cerebellar
dentate nucleus (n  7), midbrain (n  7), dorsal pons (n  6), medulla (n  4), corpus callosum (n 
4), and cerebral white matter (n  1). Brain stem lesions involved the following: tectum (n  5),
tegmentum (n  4), red nucleus (n  3) of the midbrain, vestibular nucleus (n  6), and a focal
tegmental lesion involving the superior olivary nucleus (n  6) and abducens nucleus (n  4) of the
pons and vestibular nucleus (n  4) and inferior olivary nucleus (n  1) of the medulla. DWI (n  5)
showed isointensity or hyperintensity of lesions, and the decreased ADC value was found only in the
corpus callosum lesions (n  2). All detected lesions were completely reversible at follow-up except
for the single corpus callosum lesion with an initial low ADC value.
CONCLUSION: Brain lesions were typically located at the cerebellar dentate nucleus, midbrain, dorsal
pons, medulla, and splenium of the corpus callosum. According to DWI, most of the lesions in MIE
probably corresponded to areas of vasogenic edema, whereas only some of them, located in the
corpus callosum, corresponded to cytotoxic edema.
Metronidazole-induced encephalopathy (MIE) is a raretoxic encephalopathy caused by the antibiotic drugmet-
ronidazole. Metronidazole is a nitroimidazole antibiotic and
has been available for clinical use for more than 30 years, and
it has played an important role in anaerobic-related infections
and for preventing or retarding the development of clinical
recurrence in Crohn disease. Metronidazole has good cellular
penetration and is believed to penetrate CSF and the central
nervous system easily.1 It is also comparatively safe when used
at appropriate dosages, but it can produce peripheral neurop-
athies and cerebellar dysfunction, especially at dosages exceed-
ing 2 g/day for prolonged periods.2,3 The incidence of MIE is
unknown, though several previous studies have addressed
brain change caused by metronidazole neurotoxicity.2-16 To
our knowledge, several reports on 13 patients with MIE have
documented MR brain imaging of abnormalities,7-16 and dif-
fusion-weighted imaging (DWI) data have been presented for
3 patients withMIE.11,12,14 Previous case reports have focused
on cerebellar lesions, and little radiologic investigation of MR
imaging findings with respect to brain stem pathology and
topographic lesion distribution has been performed in pa-
tients with MIE.
This study was performed to determine the topographic
distributions of lesions demonstrated on MR images and to
document the DWI findings of brain lesions in patients with
MIE.
Materials and Methods
Patients
This study included 7 patients inwhom the final clinical diagnosis was
MIE, during a period of 4 years. There were 6 men and 1 woman, and
the mean age of patients was 61 years (range, 49–71 years). Final
clinical diagnoses of MIE were determined on the basis of probable
adverse drug reactions to conventional categories of adverse drug
reactions.17 All patients had been administered metronidazole ther-
apy for several weeks before their neurologic signs and symptoms
were developed. When MIE was clinically suspected, metronidazole
medication was stopped in all patients. Thiamine had not been pre-
viously administered to any of the 7 patients during the clinical
course. Medical records were reviewed to assess clinical parameters,
such as total metronidazole dose, duration of administration, dura-
tion of symptom onset after administration, neurologic symptoms
and signs, and duration of recovery after discontinuation.
MR Imaging
All 7 patients underwentMR imaging after symptom onset. DWI was
performed in 5 patients, and follow-upMR imaging after metronida-
zole discontinuation, in 4 patients. MR imaging was performed by
using 1.5T MR imaging systems (Sonata, Siemens, Erlangen, Ger-
many; Signa Horizon and Genesis Signa, GE Healthcare, Milwaukee,
Wis; Gyroscan Intera, Philips, Best, the Netherlands). Spin-echo T1-
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weighted, fast spin-echo T2-weighted, and fast fluid-attenuated in-
version-recovery (FLAIR) images were obtained for all patients. En-
hanced T1-weighted images with gadopentetate dimeglumine
(Magnevist; Schering, Berlin, Germany) administration at 0.1
mmol/kg were also obtained in all patients. Echo-planar DWIs were
available for 5 patients. The MR imaging parameters were as follows:
450–66/12/2 (TR/TE/NEX) for spin-echo T1-weighted images,
3666–4000/96–104/1–2/7 (TR/TEeff/NEX/echo train) for fast spin-
echo T2-weighted images, and 5000–10 000/110–155/2000/1/7 (TR/
TEeff/TI/NEX/echo train) for fast FLAIR images. The other parame-
ters were the following; section thickness 5–6mmwith a 1.5-mmgap,
field of view of 240mm, and a 256 192matrix. DWIwas performed
with a single-shot spin-echo echo-planar pulse sequence with 2 dif-
fusion-sensitivity values of 0 and 1000 s/mm2 along all 3 orthogonal
axes. From all the DWI sequences, we calculated the apparent diffu-
sion coefficient (ADC) maps.
Imaging Analysis
MR images were retrospectively evaluated by 2 radiologists (D.G.N.
and E.K.) by consensus. The anatomic locations of lesions showing
hyperintensity on T2-weighted or FLAIR images and lesion enhance-
ments on enhanced T1-weighted images were assessed. Lesion signal
intensities were visually assessed on DWI, and ADCs were measured
in patients who underwent DWI. Interval changes in brain lesions
were assessed in patients with follow-up MR images.
To quantitatively determine the ADC values of lesions, we ob-
tained lesion values by manually drawing regions of interest (ROIs)
along lesion boundaries on T2-weighted images. Manually drawn
ROIs on T2-weighted images were copied to the same locations on
ADCmaps. Tomeasure ADC ratios, we alsomeasured ADC values of
normal white matter by using ROIs (mean size, 200 mm2) in the
subcortical white matter of the frontal lobe.
Results
Demographic and Clinical Data
Table 1 details the clinical presentation of the 7 patients with
MIE. The mean total dose of metronidazole administered was
58.1 g (range, 21–135 g) during a mean period of 38.7 days
(range, 14–90 days). The mean duration of medication until
the development of neurologic symptoms was 25.4 days
(range, 11–52 days). Neurologic symptoms included dysar-
thria (n  7), gait disturbance (n  5), weakness of the ex-
tremities (n  2), mental confusion (n  1), visual distur-
bance (n 1), and a tingling sensation of the extremities (n
1). Neurologic symptoms improved in all patients within a
mean of 6.7 days (range, 4–10 days) after metronidazole dis-
continuation. Mean duration between symptom onset and
initialMR imagingwas 13.4 days (range, 3–38 days), andmean
duration between medication discontinuation and follow-up
MR imaging was 20 days (range, 14–34 days).
Lesion Distribution
Table 2 demonstrates the locations and topographic distribu-
tions of lesions seen on T2-weighted and FLAIR images. These
images demonstrated bilateral symmetric hyperintense lesions
in cerebellar dentate nuclei, midbrain, dorsal pons, medulla,
corpus callosum, and cerebral white matter (Figs 1–3). Bilat-
eral symmetric involvements of cerebellar dentate nuclei and
midbrain were demonstrated in all patients. Midbrain lesions
were in the tectum (n 5, 71%), the tegmentum around peri-
aqueductal graymatter (n 4, 57%), and the red nucleus (n
3, 43%); and lesions of the dorsal pons were in the vestibular
nucleus (n 6, 86%), a focal tegmental lesion in the superior
olivary nucleus (n 6, 86%), and the abducens nucleus (n
Table 1: Demographic and clinical data of seven patients with MIE
Patient Age/Sex
Underlying
Disease
Drug
Dosage
(g)/Duration
(days) Symptoms
Medication Duration
Before Symptom
Development
(days)
Time to Clinical
Improvement
after Drug
Discontinuation
(days)
Duration
Between
Symptom Onset
and Initial MRI
(days)
Duration
Between Drug
Discontinuation
and Follow-Up
MRI (days)a
1 49/M Crohn disease 135/90 Weakness of extremities,
dysarthria, gait
disturbance
52 10 38 –
2 70/M Brain abscess,
LC
57/38 Weakness of extremities,
dysarthria
22 7 7 14
3 64/M Intraabdominal
abscess
37.5/25 Dysarthria, gait
disturbance, visual
blurring
17 7 17 17
4 54/M Spontaneous
bacterial
peritonitis,
LC
49.5/33 Dysarthria, confusion 15 5 21 –
5 71/M DM foot, CRF 66/44 Dysarthria, gait
disturbance
37 4 3 34
6 55/M Ischemic colitis,
LC
21/14 Dysarthria, gait
disturbance, tingling
sensation of both
extremities
11 7 3 15
7 61/F Pseudo-
membranous
colitis
40.5/27 Dysarthria, gait
disturbance
24 7 5 –
Note:—LC indicates liver cirrhosis; CRF, chronic renal failure; DM, diabetes mellitus.
a Follow-up MR imaging was not studied in 3 patients (patients 1, 4, and 7).
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4, 57%).18 Lesions of the medulla were in the vestibular nu-
cleus of the dorsal medulla (n  4, 57%) and the inferior
olivary nucleus (n 1, 14%). In 6 (86%) patients, MR images
showed a characteristic pattern of bilateral symmetric involve-
ment of the dentate nuclei, vestibular nuclei, and a focal area of
the tegmentum in the superior olivary nucleus at the level of
the low pons (Figs 1 and 2). Dorsal parts of the pons and
medullawere always involved in all patients whohad lesions in
the pons and medulla. The splenium was involved in all 4
patientswhohad lesions in the corpus callosum, and 2patients
showed mild corpus callosum swelling. Cerebral white matter
involvement was evident in 1 patient (14%). No lesion con-
trast enhancement was observed on enhanced T1-weighted
images.
Lesion DWI Signal Intensities and ADC Values
Table 3 shows the DWI signal intensities, ADC values, and
ADC ratios of lesions on initial MR imaging in 5 patients (pa-
tients 1 and 4–7) and follow-upMR imaging in 1 patient (pa-
tient 6). DWI signal intensities were variable, from hyperin-
tense to isointense in lesions of the dentate nucleus, midbrain,
medulla, and pons (Figs 1 and 2). The lesions of the corpus
callosum were hyperintense (Figs 1 and 2). Mean ADC and
ADC ratio values of the spleniumwere 515 106 mm2/s and
0.7, respectively. Although the ADC values of lesions of the
dentate nucleus, midbrain, medulla, and pons were similar or
C
A B
Fig 1. A 54-year-old man (patient 4) with spontaneous bacterial peritonitis. A, Axial FLAIR
(TR/TE/TI  6000/120/2000 ms) images demonstrate bilateral symmetric hyperintense lesions
in the dorsal medulla (black thick arrows), vestibular (black thin arrows), abducens (white
arrows), and a focal tegmental lesion of the superior olivary nuclei (arrowheads) of the dorsal
pons, dentate nuclei of the cerebellum, red nuclei and tegmentum of the midbrain, and the
splenium of the corpus callosum. B, DWIs (TR/TE  3396/60) show bright signal intensity at
the peripheral part of the cerebellar dentate nuclei and central part of the splenium. The lesions
of the low pons and tegmentum of the midbrain are slightly hyperintense, and the lesions of
dorsal medulla and central part of dentate nuclei are isointense on DWI. C, ADC maps show
a focal area of low ADC in the splenium of the corpus callosum (black arrow) and a high ADC
area in most areas of the dentate nuclei (white arrows).
Table 2: Lesion distribution on T2-weighted and FLAIR MR images in the seven patients with MIE
Patient
Cerebellum
(Dentate Nuclei)
Medulla Pons Midbrain
Corpus
Callosum
Subcortical
WM
Dorsal
Medulla ION VN AN SON Tectum Tegmentum RN
1           
2           
3           
4           
5           
6           
7           
Note:—WM indicates white matter; ION, inferior olivary nucleus; VN, vestibular nucleus; AN, abducens nucleus; SON, superior olivary nucleus; RN, red nucleus; , presence of lesion
at each anatomic location; , no abnormality on MR at each anatomic location.
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higher than those of normal white matter, ADC values were
lower in corpus callosum lesions than in normal white matter.
Reversibility of Lesions
Hyperintense lesions on T2-weighted and FLAIR images were
found to be completely reversible in follow-upMR images in 3
patients (Fig 3) and partially reversible in 1 patient (Fig 2). In
1 of 3 patients with lesions of the corpus callosum, focal resid-
ual hyperintensities were observed only in the splenium on
follow-upMR images (Fig 2). Lesions other than in the corpus
callosum had disappeared in all 4 patients at follow-up MR
imaging. No lesion was found not to have changed or in-
creased by follow-up MR imaging.
Discussion
Our study demonstrates that the typical locations of lesions by
MR imaging in patients with MIE are the cerebellar dentate
nuclei, midbrain (tectum, red nucleus, and tegmentum
around periaqueductal gray matter),
dorsal pons (the vestibular nucleus, a fo-
cal tegmental lesion of the superior oli-
vary nucleus, and the abducens nucleus),
dorsal medulla, and corpus callosum
(splenium); and these lesions were al-
ways bilateral and symmetric. Uncom-
mon locations were the inferior olivary nucleus and the white
matter of the cerebral hemispheres.
Lesions of the cerebellar nuclei, olivary nuclei, and brain
stem as demonstrated onMR images in patients with MIE are
explained by the histologic findings of previous experimental
animal studies.19-22 A toxicologic study19 in rats demonstrated
well-demarcated usually symmetric lesions in the vestibular
nuclei, cochlear nuclei, rostral colliculus, cerebellar nuclei,
and olivary nuclei after the administration of high doses of
metronidazole, and these lesions were characterized as spon-
giform changes within neurons. A similar experimental study
in dogs demonstrated the degeneration and selective loss of
Purkinje cells20 and mild swelling of axon sheaths in vestibu-
lar-cerebellar white matter tracts and leukomalacia near the
vestibular nerve radix.21 According to a recent study in cats,
multifocal well-demarcated foci of necrosis were present in
central brain stem regions from the diencephalon to the me-
dulla oblongata.22However, no documented data are available
BA
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Fig 2. A 55-year-old man with ischemic colitis (patient 6). A,
Axial T2-weighted (TR/ TE 5000/110) images demonstrate
bilateral symmetric hyperintense lesions in the dorsal me-
dulla, vestibular, abducens, and focal tegmental lesions of
the superior olivary nuclei of the dorsal pons, dentate nuclei
of the cerebellum, the tectum of the midbrain, and the
splenium of the corpus callosum. B, DWI (TR/TE 4000/73)
and ADC maps show mild hyperintensity and slightly high
ADC of the dentate nuclei and obvious hyperintensity and
very low ADC of the splenium of the corpus callosum. C,
Follow-up MR images obtained 15 days after drug discon-
tinuation. T2-weighted images show that the hyperintense
lesions of the dentate nucleus and pons have disappeared,
but a residual hyperintense lesion is seen in the splenium of
corpus callosum. Note the near normalization of ADC and
residual hyperintensity of the residual splenium lesion on
DWI.
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onhistologic changes in hemisphericwhitematter, corpus cal-
losum, and basal ganglia in experimentally induced metroni-
dazole neurotoxicity.
According to the previously reported 13 cases of MIE,7-16
cerebellar dentate nuclei are most commonly involved onMR
images, and this was found in 100% of our 7 cases and in 10 of
the 13 previously reported cases. Less common locations in-
cluded the corpus callosum (n  6), midbrain (n  4), basal
ganglia (n 4), and cerebral subcortical whitematter (n 4).
Previous reports have also found involvements of the dorsal
medulla (n  2), dorsal pons (n  1), inferior olivary nuclei
(n 1), and anterior commissure (n 1). The accumulated
data of our cases and previously reported cases show that the
lesion distribution of MIE is as follows: cerebellar dentate nu-
clei (n 17, 85%), midbrain (n 11, 55%), corpus callosum
(n 10, 50%), pons (n 7, 35%), medulla (n 6, 30%), and
subcortical white matter of the hemisphere (n 5, 25%) and
basal ganglia (n 4, 20%) in a total of 20 patients of our cases
and previously reported cases.
Although the anatomic detail of brain stem lesions was not
described by previous case reports, the present study demon-
strates topographic distributions of lesions in the midbrain,
pons, andmedulla onMR imaging.Midbrain lesions involved
the tectum, tegmentum, and red nucleus; and structural in-
volvements varied. For the lesion in the pons, MR images
showed a characteristic pattern of vestibular and abducens
nuclei of the dorsal pons and a focal tegmental lesion of the
superior olivary nucleus at the level of the low pons. All 4
patients with medullary lesions showed a linear T2 hyperin-
tense lesion of the vestibular nuclei of the floor of the fourth
ventricle at the dorsal medulla. The findings of the present
study and of previous studies suggest that patients with MIE
share characteristic MR imaging lesion features and distribu-
tions. First, lesions are always symmetric and bilateral, which
is a typical pattern of metabolic encephalopathy. Second, bi-
lateral cerebellar dentate nuclei are involved in most cases.
Third, the MR imaging feature of bilateral symmetric lesions
in the dentate nuclei, vestibular nuclei, and a focal tegmental
lesion in the superior olivary nuclei of the low pons is a char-
acteristic pattern in patients with lesions of the pons. Fourth,
lesions of the corpus callosum always involve the splenium.
The involvement of the inferior olivary nucleus inMIE has
previously been reported in only 1 patient.12 Seok et al12 ob-
served that increased signal intensity of the inferior olivary
nuclei did not change during follow-upMR imaging, whereas
that of other lesions disappeared. They suggested that a lesion
of the inferior olivary nucleus may be inferred to be the result
of lesions that interrupt the circuit of the Guillain-Mollaret
triangle, rather than being a result of lesions induced by met-
A B
Fig 3. A 64-year-old man with an intra-abdominal abscess (patient 3). A, Axial FLAIR (TR/TE/TI  10,000/122/2000) images show bilateral symmetric hyperintense lesions in the inferior
olivary nuclei (arrows) and dorsal medulla, dorsal pons, cerebellar dentate nuclei, splenium and genu of corpus callosum, and subcortical white matter of both cerebral hemispheres. B,
Follow-up FLAIR images obtained 17 days after drug discontinuation show complete reversal of all lesions.
Table 3: Signal intensities and ADC values of lesions of DWI on
initial MR imaging in five patients and follow-up MR imaging in
one patient
Lesions
Signal
Intensity
on DWI
(High/
Mixed/Iso)
ADC Value
(106 mm2/s)
ADC
Ratioa
Initial patients (n  5)
Cerebellar dentate nucleus
(n  5)
2/2/1 885 67 1.2 0.06
Midbrain (n  5)
Tectum (n  3) 2/0/1 872 59 1.1 0.10
Red nucleus (n  2) 1/1/0 929 2 1.3 0.01
Tegmentum around peri-
aqueductal GM (n  2)
2/0/0 1021 59 1.5 0.09
Dorsal pons (n  4) 2/0/2 844 75 1.1 0.16
Dorsal medulla (n  3) 1/1/1 959 162 1.3 0.25
Splenium (n  2) 2/0/0 515 195 0.7 0.30
Follow-up patient (n  1)
Cerebellar dentate nucleus
(n  1)
(0/0/1) 734 1.0
Splenium (n  1) (1/0/0) 1097 1.4
Note:—Iso indicates isointense; GM, gray matter.
a ADC values and ratios are presented as mean  SD. ADC ratio is the ratio of the ADC
value of a lesion to that of normal subcortical white matter.
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ronidazole therapy. However, in 1 patient (Fig 3) of the
present study, the lesions of the bilateral olivary nuclei and
other lesions disappeared at follow-up MR imaging per-
formed after drug discontinuation. It is unclear whether le-
sions of the inferior olivary nuclei in MIE are caused by direct
neurotoxic injury by metronidazole or by hypertrophic oli-
vary degeneration.
Diffusion changes of lesions in patientswithMIE are some-
what controversial. The previous case reports11,12,14 suggested
vasogenic edema of the lesions in the cerebellar dentate nuclei
and cytotoxic edema of lesions in the internal capsule, anterior
commissure, splenium, and subcortical white matter. In the
present study, DWI showed increased ADC value and vaso-
genic edema in lesions of the midbrain, pons, medulla, and
cerebellar dentate nuclei, which involve mainly gray matter,
but decreasedADCvalue and cytotoxic edema in lesions of the
corpus callosum. Some lesions showing DWI hyperintensity
and no lowADC value could be explained by T2 shinethrough
effect.
Although it is unclear why lesion ADC values depend on
lesion location, we presume that mechanisms of metronida-
zole neurotoxicity may differ for white matter lesions and le-
sions predominantly of gray matter. However, because heter-
ogeneous DWI signal intensities in lesions showing T2
hyperintensity were observed in some patients, it could be that
lesion ADC values might simply reflect differences in degrees
of edema, whether vasogenic or cytotoxic in nature. More-
over, diffusion signal-intensity change may be also related to
the stage of neurotoxic injury and the time interval lapsed
between initial and follow-upMR imaging. The present study
shows incomplete resolution of a lesion of the splenium of the
corpus callosum in only 1 patient, in whom this lesion had a
very low ADC value (377 106 mm2/s) (Fig 2). In the other
patient who had a splenial lesion on the initial DWI, the ADC
value of the lesion was also low (653 106mm2/s); however,
the reversibility of the lesion could not be assessed due to no
follow-up DWI.
Previous studies4-6 have suggested several mechanisms of
metronidazole neurotoxicity, ie, the RNA binding,4 DNA
binding5 of intermediate metabolites of metronidazole, and
the modulation of the inhibitory neurotransmitter g-ami-
nobutyric acid receptor within the cerebellar and vestibular
systems.6 Although the mechanism of metronidazole neuro-
toxicity remains unclear, most lesions induced by metronida-
zole neurotoxicity may be wholly reversible.
AcuteWernicke encephalopathy is themost important dis-
ease in the differential diagnosis of MIE. Acute Wernicke en-
cephalopathy and MIE may be clinically confused during the
early clinical stage because MIE may produce similar clinical
conditions and symptoms. The MR imaging features of MIE
may also mimic Wernicke encephalopathy. Typically the MR
imaging features of acute Wernicke encephalopathy are bilat-
eral symmetric T2 hyperintense lesions in the periventricular
regions of the mammillary body, medial thalamus, floors of
the third and fourth ventricles, periaqueductal gray matter,
andmidbrain tectum.23 Less commonMR imaging features of
Wernicke encephalopathy include the involvements of peri-
central cortices,24 basal ganglia,24 and the superior cerebellar
vermis.25,26 Recently, Bae et al27 and Kang et al28 reported 2
cases of acute nonalcoholic Wernicke encephalopathy with
atypical MR imaging features. These 2 cases had almost the
sameMR imaging feature of bilateral symmetric lesions at the
dentate nuclei, vestibular nuclei, and at focal areas of the teg-
mentum. This MR imaging feature was not reported by previ-
ous studies of Wernicke encephalopathy, and it is consistent
with MR imaging findings of MIE, as documented by the
present study. In the previously mentioned case reports,27,28
metronidazole had been administrated for a prolonged period
until symptoms developed (S.J. Bae and G. Choi, personal
communications, December 2006), and the authors did not
rule out the possibility ofMIE. Therefore, it is unclear whether
the previously reported atypical MR imaging features were
due to acute Wernicke encephalopathy or MIE or both. Al-
though lesions of the cerebellar vermis reported in Wernicke
encephalopathy25,26 are explained by histologic cerebellar
changes found in this condition, lesions of cerebellar dentate
nuclei are not supported by pathology studies on Wernicke
encephalopathy.29,30
AlthoughMR imaging findings of bilateral involvement of
the dentate nuclei are a very characteristic feature of MIE, the
differential diagnosis of T2 hyperintense lesions of the bilat-
eral cerebellar dentate nuclei in patients with symptoms of
acute encephalopathy includes methyl bromide intoxica-
tion,31 maple syrup urine disease,32 and enteroviral encepha-
lomyelitis.33 Brain stem lesions of metronidazole neurotoxic-
ity should be differentiated from those of central pontine
myelinolysis with or without extrapontine myelinolysis.
Whereas pontine myelinolysis involves the basis pontis and
may show restricted diffusion of pons lesions on DWI,34 MIE
affects the dorsal pons region and has no restricted diffusion
on DWI in most cases. The differential diagnosis of T2 hyper-
intense focal lesions in the corpus callosum splenium includes
various demyelinating diseases (eg,Marchiafava-Bignami dis-
ease, encephalitis, osmoticmyelinolysis, and transient splenial
lesions). The etiologies of transient T2 hyperintense focal le-
sions in the splenium of the corpus callosum include patients
with epilepsy treated with antiepileptic drugs,35 acute infec-
tious encephalitis (influenza, Escherichia coli, mumps, adeno-
virus, Epstein-Barr virus, and Rota virus),36-39 demyelinating
lesions including osmotic myelinolysis, and acute toxic en-
cephalopathy (methotrexate and 5-fluorouracil).40-41
The present study has several limitations. First, the
number of patients included was small, and follow-up MR
images were obtained in a limited number of patients. Sec-
ond, further study is needed to determine the clinical sig-
nificance of lesion ADC values with respect to the predic-
tion of clinical outcome.
Conclusion
The brain lesions demonstrated on MR images in MIE were
always bilateral and symmetric and were typically located at
the cerebellar dentate nuclei, dorsal medulla, dorsal pons,
midbrain, and splenium of the corpus callosum. Uncommon
lesion locations were the inferior olivary nucleus of the me-
dulla andwhitematter of the cerebral hemispheres. According
to DWI, most of the lesions in MIE probably correspond to
areas of vasogenic edema, whereas only some of them, located
in the corpus callosum, correspond to cytotoxic edema.
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